These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The current status of erythromycin, kanamycin, novobiocin, oleandomycin, ristocetin, and vancomycin, with particular reference to their use in staphylococcal disease; panel discussion. FINLAND M; FOLTZ E; GERACI JE; KIRBY WM; QUINN EL; ROMANSKY MJ; YOW EM Antibiot Annu; 1958-1959; 6():1051-72. PubMed ID: 13637882 [No Abstract] [Full Text] [Related]
24. Management of staphylococcal infections with antibiotic combinations. HALL WH Rocky Mt Med J; 1958 Jul; 55(7):40-1. PubMed ID: 13555626 [No Abstract] [Full Text] [Related]
25. [Therapy of facial carbuncle]. SCHULTHEISS E Z Haut Geschlechtskr; 1957 Jun; 22(11):346-9. PubMed ID: 13456769 [No Abstract] [Full Text] [Related]
26. [Combined penicillin and chloramphenicol therapy of penicillin-resistant staphylococcal infections]. ORTONA L; SORICE F Minerva Med; 1954 Jun; 45(47):1739-44. PubMed ID: 13193733 [No Abstract] [Full Text] [Related]
28. A critical clinical evaluation of kanamycin in severe infections. DUKE CJ; KATZ S; DONOHOE F; FEDORKO J Antibiot Annu; 1958-1959; 6():595-604. PubMed ID: 13637807 [No Abstract] [Full Text] [Related]
29. Not to be forgotten aids in the treatment of antibiotic resistant staphylococcus skin infections. SWARTS WB Conn Med; 1958 Dec; 22(12):820-1. PubMed ID: 13609184 [No Abstract] [Full Text] [Related]
30. Treatment of soft-tissue infections. PULASKI EJ Antibiotic Med Clin Ther (New York); 1957 Oct; 4(10):657-67. PubMed ID: 13470839 [No Abstract] [Full Text] [Related]
31. [Management of staphylococcal toxoid]. LITHANDER A Sven Lakartidn; 1956 Dec; 53(50):3357-62. PubMed ID: 13391651 [No Abstract] [Full Text] [Related]
32. [Staphylococcia & its treatment]. Med Cir Farm; 1957 Jun; 19(254):255-6. PubMed ID: 13464328 [No Abstract] [Full Text] [Related]
33. [How is a persistent staphylococcal infection treated medically?]. POINSO R Mars Med; 1957; 94(5):305-11. PubMed ID: 13440192 [No Abstract] [Full Text] [Related]
35. [Results with erycinum in internal diseases]. FRICKE G Z Gesamte Inn Med; 1957 Jun; 12(11):497-501. PubMed ID: 13468608 [No Abstract] [Full Text] [Related]
37. Antibiotic therapy: clinical application of available agents. SCHIRGER A; MARTIN WJ; NICHOLS DR GP; 1959 Feb; 19(2):102-8. PubMed ID: 13619965 [No Abstract] [Full Text] [Related]
38. [Considerations on the discrepancies between in vitro sensitivity and clinical results in antibiotic therapy of infections caused by Staphylococcus pyogenes aureus]. GRASSI GC Biol Lat; 1958; 11(2):273-81. PubMed ID: 13546207 [No Abstract] [Full Text] [Related]
39. [Production of a staphylococcal autovaccine and its therapeutic use in skin diseases]. MILDSCHLAG G; ORTEL S Dermatol Wochenschr; 1958 Jun; 137(25):658-61. PubMed ID: 13573886 [No Abstract] [Full Text] [Related]
40. [Vulcamycin (novobiocin) in treatment of certain surgical infections caused by Staphylococcus aureus]. LUPI A Minerva Med; 1957 Jan; 48(8):266-70. PubMed ID: 13418476 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]